Email UpdatesLiterature Collection
Collection Insights
12K+
References
11K+
Articles
1600+
Grey Literature
4800+
Opioids & SU
The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More
Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).
12771 Results
10724
Tactics to improve adherence in depressed primary care patients
Type:
Journal Article
Year:
2016
Publication Place:
United States
Topic(s):
General Literature
See topic collection
Reference Links:
View the DOI record for Tactics to improve adherence in depressed primary care patients
View DOI Record
View the PubMed citation for Tactics to improve adherence in depressed primary care patients
10725
Tailored internet-administered treatment of anxiety disorders for primary care patients: study protocol for a randomised controlled trial
Type:
Journal Article
Year:
2012
Publication Place:
England
Abstract:
BACKGROUND: Internet-administered cognitive behavioural therapy (ICBT) has been found to be effective for a range of anxiety disorders. However, most studies have focused on one specific primary diagnosis and co-morbidity has not been considered. In primary care settings, patients with anxiety often suffer from more than one psychiatric condition, making it difficult to disseminate ICBT for specific conditions. The aim of this study will be to investigate if ICBT tailored according to symptom profile can be a feasible treatment for primary care patients with anxiety disorders. It is a randomised controlled trial aimed to evaluate the treatment against an active control group. METHODS: Participants with anxiety disorders and co-morbid conditions (N = 128), will be recruited from a primary care population. The Clinical Outcome in Routine Evaluation (CORE-OM) will serve as the primary outcome measure. Secondary measures include self-reported depression, anxiety, quality of life and loss of production and the use of health care. All assessments will be collected via the Internet and measure points will be baseline, post treatment and 12 months post treatment. DISCUSSION: This trial will add to the body of knowledge on the effectiveness of ICBT for anxiety disorders in primary care. The trial will also add knowledge on the long term effects of ICBT when delivered for regular clinic patients TRIAL REGISTRATION: ClinicalTrials.gov: NCT01390168.
Topic(s):
HIT & Telehealth
See topic collection
10726
Tailored interventions to implement recommendations for elderly patients with depression in primary care: a study protocol for a pragmatic cluster randomised controlled trial
Type:
Journal Article
Year:
2014
Publication Place:
England
Abstract:
BACKGROUND: The prevalence of depression is high and the elderly have an increased risk of developing chronic course. International data suggest that depression in the elderly is under-recognised, the latency before clinicians provide a treatment plan is longer and elderly patients with depression are not offered psychotherapy to the same degree as younger patients. Although recommendations for the treatment of elderly patients with depression exist, health-care professionals adhere to these recommendations to a limited degree only. We conducted a systematic review to identify recommendations for managing depression in the elderly and prioritised six recommendations. We identified and prioritised the determinants of practice related to the implementation of these recommendations in primary care, and subsequently discussed and prioritised interventions to address the identified determinants. The objective of this study is to evaluate the effectiveness of these tailored interventions for the six recommendations for the management of elderly patients with depression in primary care. METHODS/DESIGN: We will conduct a pragmatic cluster randomised trial comparing the implementation of the six recommendations using tailored interventions with usual care. We will randomise 80 municipalities into one of two groups: an intervention group, to which we will deliver tailored interventions to implement the six recommendations, and a control group, to which we will not deliver any intervention. We will randomise municipalities rather than patients, individual clinicians or practices, because we will deliver the intervention for the first three recommendations at the municipal level and we want to minimise the risk of contamination across GP practices for the other three recommendations. The primary outcome is the proportion of actions taken by GPs that are consistent with the recommendations. DISCUSSION: This trial will investigate whether a tailored implementation approach is an effective strategy for improving collaborative care in the municipalities and health-care professionals' practice towards elderly patients with depression in primary care. The effectiveness evaluation described in this protocol will be accompanied with a process evaluation exploring why and how the interventions were effective or ineffective. TRIAL REGISTRATION: ClinicalTrials.gov: NCT01913236.
Topic(s):
Healthcare Disparities
See topic collection
10730
Take Charge, Get Cured: The development and user testing of a culturally targeted mHealth decision tool on HCV treatment initiation for methadone patients
Type:
Journal Article
Year:
2018
Publication Place:
Ireland
Topic(s):
HIT & Telehealth
See topic collection
, Measures
See topic collection
, Opioids & Substance Use
See topic collection
10731
Take home maintenance medication in opiate dependence
Type:
Journal Article
Year:
2013
Publication Place:
Germany
Abstract:
BACKGROUND: Opiate-dependent patients can be given several days' worth of maintenance medication to take home. We studied whether the patients chosen to receive take home maintenance medication met the criteria that were published in the guidelines of the German Medical Association. These include, among other things: abstinence from additional consumption of heath-endangering substances, psychosocial reintegration, completion of the switch from illegal narcotics to the substitute maintenance medication, and clinical stabilization. METHODS: In this study, data were obtained by questionnaire over the period from May to October 2011 from patients of all 20 psychiatric hospitals and all 110 physicians' practices with licenses to provide opiate maintenance medication in Berlin, Germany. RESULTS: 986 (19.9%) of the 5032 patients taking opiate medication answered the study questionnaire; 956 gave information about the frequency with which they received medication. 365 of these 956 patients (38.2%) reported having received take home medication. Among them, 197 (56.0%) said that they additionally consumed health-endangering substances, compared to 388 (69.9%) of those who received maintenance medication every day (p<0.0001). Lower rates of additional consumption among recipients of take home maintenance medication were also found for each of the substances heroin, cocaine, and benzodiazepines (p<0.0001 for each). Patients receiving take home medication more commonly indicated that they were employed and tended to have been in the maintenance program longer than patients receiving maintenance medication every day (p<0.0001 for each question). Clinical stabilization, i.e., improvement of mental and physical health, was reported in equal measure by patients who were and were not receiving take home medication. CONCLUSION: The patient questionnaire reveals that most patients receiving take home maintenance medication meet the criteria specified in the guidelines of the German Medical Association.
Topic(s):
Opioids & Substance Use
See topic collection
10733
Take-home naloxone and the politics of care
Type:
Journal Article
Year:
2019
Publication Place:
England
Topic(s):
Opioids & Substance Use
See topic collection
10734
Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals
Type:
Journal Article
Year:
2020
Publication Place:
United States
Topic(s):
Education & Workforce
See topic collection
, Healthcare Policy
See topic collection
, Opioids & Substance Use
See topic collection
Reference Links:
View the DOI record for Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals
View DOI Record
View the PubMed citation for Take-Home Naloxone Program Implementation: Lessons Learned From Seven Chicago-Area Hospitals
10736
Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems
Type:
Journal Article
Year:
2017
Publication Place:
England
Abstract:
INTRODUCTION: Naloxone reversal of opioid-induced respiratory depression outside of medical facilities has become more prevalent because of the escalating opioid epidemic in the USA. Take-home naloxone for treatment of opioid emergencies is now being recommended by numerous federal, state, and professional organizations. Areas covered: The scope of the opioid overdose epidemic is reviewed along with practical, clinical, regulatory, and usability considerations for take-home naloxone routes of administration currently available and associated delivery systems. Specific opioid-related factors are discussed in detail with emphasis placed on life-threatening respiratory depression and naloxone antagonism. A clinical overview, including pharmacokinetic and FDA approval information for each take-home naloxone product is discussed in detail as well as the impact of take-home naloxone in the community. Finally, given these products are to be used in a panic-stricken, life-threatening opioid emergency, an analysis of available usability data is provided with proposed directions for further study. Expert opinion: Based on the available clinical evidence, auto-injectable naloxone should be the preferred administration route for take-home naloxone treatment until additional safety, efficacy, and comparative outcomes data are available for unconventional routes of administration that unequivocally provide equal or superior results.
Topic(s):
Opioids & Substance Use
See topic collection
10739
Taking Action on the Workforce Crisis
Type:
Journal Article
Year:
2018
Abstract:
This article discusses workforce problems in behavioral health, the lack of progress in addressing these problems, and the scarcity of efforts under way to strengthen the workforce.
Topic(s):
Education & Workforce
See topic collection
Reference Links:
View the DOI record for Taking Action on the Workforce Crisis
View DOI Record
View the PubMed citation for Taking Action on the Workforce Crisis